Is CoQ10 worth taking? Especially on a statin?

CoQ10 supplementation at 100–300 mg/day has Promising (2) evidence for reducing statin-induced myalgia (muscle pain and weakness) in the subset of statin users who experience it, the proposed mechanism is that statin-induced inhibition of the mevalonate pathway reduces endogenous CoQ10 synthesis in muscle, and supplementation may partially compensate, but systematic reviews have shown inconsistent benefit, with some studies showing relief and others showing no effect (Banach et al., Semin Arthritis Rheum, 2015).

For men not on statins, CoQ10's general cardiovascular benefit claim is Early (3). The hypothesis that declining CoQ10 levels with age contribute to mitochondrial dysfunction and cardiovascular disease is mechanistically plausible, but clinical trials of CoQ10 supplementation for cardiovascular outcomes have been small and inconsistent. The Q-SYMBIO trial showed benefit in heart failure patients, but this is a specific disease population, not healthy men.

Honesty Scale: CoQ10 for statin myalgia, Promising (2) with inconsistent trial evidence. CoQ10 for cardiovascular health in healthy men, Early (3).

What to do: If you are on a statin and experiencing muscle pain, a trial of CoQ10 100–200 mg/day for 3 months is reasonable, the safety profile is excellent and the cost is low. If you are not on a statin and are considering CoQ10 for general cardiovascular health, the evidence is too inconsistent to make it a priority over the Solid (1) interventions.

For the full picture, read The Supplementation Deep Dive